SI — Shoulder Innovations, Inc. stock price, charts and financials

QT48Shoulder Innovations, Inc.

Shoulder Innovations, Inc. (NYSE: SI) is a Healthcare company in the Medical - Specialties industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
17.80
-0.09-0.50%
OverviewShort InterestFilings
SIQT48Shoulder Innovations, Inc.·NYSE
17.80-0.50%
News
Down 0.5% — Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript (SeekingAlpha).
Medium confidence
TA
Loading chart...
Signal & projected range
Insider open-market saleHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
MOBI+1.40%$10.86MASS+10.69%$10.98LAB+2.95%$0.73BWAY+0.52%$13.53MLAB+1.48%$127.14QDEL+2.97%$11.09STE-0.89%$208.04ALC-1.69%$65.18
Snapshot
Index-P/E-EPS (ttm)-1.71Insider Own-Shs Outstand20.74MPerf Week-6.86%
Market Cap369.14MForward P/E-EPS next Y-1.57Insider Trans-2.05%Shs Float18.12MPerf Month-15.76%
Enterprise Value285.14MPEG-EPS next Q-Inst Own-Short Float1.66%Perf Quarter-0.95%
Income-35.00MP/S6.15EPS this Y-9.85%Inst Trans-Short Ratio2.45Perf Half Y16.95%
Sales60.00MP/B2.98EPS next Y16.43%ROA-23.05%Short Interest301.54KPerf YTD24.48%
Book/sh5.98P/C3.73EPS next 5Y-ROE-25.67%52W High24.60 -27.64%Perf Year13.38%
Cash/sh4.77P/FCF-EPS past 3/5Y-ROIC-25.25%52W Low10.92 63.00%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin77.34%Volatility4.95% 5.39%Perf 5Y-
Dividend TTM-EV/Sales4.75EPS Y/Y TTM-122.08%Oper. Margin-58.53%ATR (14)1.14Perf 10Y-
Dividend Ex-Date-Quick Ratio8.92Sales Y/Y TTM87.50%Profit Margin-58.33%RSI (14)30.11Recom2.00
Dividend Gr. 3/5Y-Current Ratio10.71EPS Q/Q-115.42%SMA20-12.24%Beta0.29Target Price23.50
Payout0.00%Debt/Eq0.11Sales Q/Q54.55%SMA50-15.18%Rel Volume1.29Prev Close17.89
Employees74LT Debt/Eq0.11EarningsSep 08SMA2008.34%Avg Volume120.98KPrice17.80
IPO DateJul 31, 2025Option/ShortYes / YesEPS/Sales Surpr.-0.10% 14.94%Net Debt/EBITDA0.29Volume155,708Change-0.50%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-10-26ReiteratedUBSBuy$27 → $28
Jul-28-26InitiatedUBSBuy$27
May-08-26ReiteratedPiper SandlerOverweight$18 → $19
Dec-02-25ReiteratedMorgan StanleyOverweight$18 → $23
Aug-25-25InitiatedMorgan StanleyOverweight$13 → $18
Aug-25-25InitiatedJefferiesBuy$19
Aug-25-25InitiatedPiper SandlerOverweight$18
Aug-25-25InitiatedGoldman SachsBuy$10 → $20
Jan-09-23ReiteratedMorgan Stanley$24 → $13
Jan-09-23ReiteratedWedbush$45 → $9.00
Latest News· Times ET
Sep-15-26
Sep-15-2610:51PM
Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeekingAlpha
Sep-10-26
Sep-10-2612:05PM
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launchprnewswire.com
Sep-09-26
Sep-09-2612:28PM
Shoulder Innovations Enters Into Exclusive Collaboration With ALM Ortho For Bespoke Shoulder Implant; Financial Terms Remain ConfidentialBenzinga
12:24PM
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Proceduresprnewswire.com
Sep-08-26
Sep-08-2612:05PM
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScienceprnewswire.com
Sep-01-26
Sep-01-2612:05PM
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conferenceprnewswire.com
Aug-28-26
Aug-28-2602:53PM
Shoulder Innovations (SI) Price Target Increased by 14.13% to 26.78Fintel
Aug-10-26
Aug-10-2612:21PM
UBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28Benzinga
03:00AM
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officerprnewswire.com
Aug-08-26
Aug-08-2610:06PM
Shoulder Innovations Q2 Earnings Call Highlightsmarketbeat.com
Aug-06-26
Aug-06-2606:18PM
Shoulder Innovations (NYSE:SI) Posts In-Line Q2 Results, Raises Full-Year OutlookChartMill
04:24PM
Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcriptseekingalpha.com
04:12PM
Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimateszacks.com
12:05PM
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlookprnewswire.com
Jul-29-26
Jul-29-2612:05PM
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conferenceprnewswire.com
Company

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue604732—
Cost of Goods Sold Incl. D&A14117—
Gross Profit463624—
Selling, General and Administrative Excl. Other695535—
Research and Development1284—
Other Operating Expense1-10—
Operating Income-35-26-15—
Interest Expense-101—
Unusual Expense
————
Non-Operating Income (Expense)-1-140—
Net Income Before Taxes-35-40-16—
Income Taxes
000—
Consolidated Net Income-35-40-16—
Net Income From Continuing Operations-35-40-16—
Net Income-35-40-16—
EPS (Recurring)-1.71-1.96-0.77—
EPS (Basic, Before Extraordinaries)-1.71-1.96-0.77—
EPS (Diluted)-1.71-1.96-0.77—
EBITDA-33-37-12—
Other After Tax Adjustments
————
Stock Option Compensation Expense
————
Price To Earnings Ratio
————
Price To Sales Ratio6.236.39——
Gross Margin76.6776.6075.00—
Operating Margin-58.33-55.32-46.88—
Net Margin-58.33-85.11-50.00—
Shares Outstanding212120—
Market Capitalization374300——
Operating Lease Expense
————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.24$21.93$17.63$13.33$9.02● Close Price0.00M0.95M1.89M2.84M3.79MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ball Robert JosephCEO & Executive ChairmanSep 14 '26Option Exercise2.1089,233187,282390,999Sep 14
Ball Robert JosephCEO & Executive ChairmanSep 14 '26Sale18.4510,175187,706380,824Sep 14
Gilde Healthcare Holding B.V.10% OwnerAug 26 '26Sale22.601,19627,0302,185,914Aug 28
Gilde Healthcare Holding B.V.10% OwnerAug 24 '26Sale22.6268115,4042,187,110Aug 24
Gilde Healthcare Holding B.V.10% OwnerAug 21 '26Sale22.6120,516463,8672,187,791Aug 24
Gilde Healthcare Holding B.V.10% OwnerAug 20 '26Sale22.603,90088,1402,208,307Aug 24
Ahearn Matthew FraserChief Operating OfficerAug 18 '26Sale20.9914,186297,704244,176Aug 18
Ahearn Matthew FraserChief Operating OfficerAug 17 '26Sale20.108,314167,101258,362Aug 18
Gilde Healthcare Holding B.V.10% OwnerAug 06 '26Sale22.602,09547,3472,212,207Aug 07
Gilde Healthcare Holding B.V.10% OwnerAug 05 '26Sale22.647,338166,1322,214,302Aug 07
Gilde Healthcare Holding B.V.10% OwnerAug 04 '26Sale22.7799,8122,272,7192,221,640Aug 05
Gilde Healthcare Holding B.V.10% OwnerAug 03 '26Sale22.7110,751244,1552,321,452Aug 05
Gilde Healthcare Holding B.V.10% OwnerJul 31 '26Sale22.7320,034455,3732,332,203Aug 03
Gilde Healthcare Holding B.V.10% OwnerJul 30 '26Sale23.3628,245659,8032,352,237Aug 03
Ahearn Matthew FraserChief Operating OfficerJun 15 '26Sale18.844,14478,070269,176Jun 16
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.